S.V. Labs Profile
Key Indicators
- Authorised Capital ₹ 31.10 Cr
as on 18-06-2024
- Paid Up Capital ₹ 6.04 Cr
as on 18-06-2024
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 49.85 Cr
as on 18-06-2024
- Satisfied Charges ₹ 19.17 Cr
as on 18-06-2024
About S.V. Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 31.10 Cr and a paid-up capital of Rs 6.04 Cr.
The company currently has active open charges totaling ₹49.85 Cr. The company has closed loans amounting to ₹19.17 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at S.V. Labs Private Limited India is Abhishek Lohia as COMPANY SECRETARY. Kalidindi Raju and Srinivas Vasireddy serve as directors at the Company.
- CIN/LLPIN
U24239TG2003PTC041662
- Company No.
041662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at S.V. Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Lohia  | Company Secretary | 10-May-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kalidindi Raju | Director | 26-Aug-2019 | Current |
| Srinivas Vasireddy | Director | 20-Oct-2022 | Current |
Financial Performance of S.V. Labs.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of S.V. Labs?
Unlock access to S.V. Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vandana Life Sciences Private LimitedActive 22 years 7 daysKalidindi Raju and Srinivas Vasireddy are mutual person
- Vindhya Pharma (India) Private LimitedActive 18 years 5 months
Kalidindi Raju and Srinivas Vasireddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Sep 2023 | ₹2.00 Cr | Open |
Others Creation Date: 23 Feb 2021 | ₹1.74 Cr | Open |
Others Creation Date: 27 May 2020 | ₹22.00 Cr | Open |
How Many Employees Work at S.V. Labs?
Unlock and access historical data on people associated with S.V. Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of S.V. Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.V. Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
